A Major Market Puts the Pandemic in the Rearview Mirror

There's only one way to know when a market has moved on from a crisis... when a market completely erases the losses it endured from the terrible event. That happened for the U.S. market in August 2020. Now, it's happening in German stocks... [Stansberry Research Logo] Delivering World-Class Financial Research Since 1999 [DailyWealth] A Major Market Puts the Pandemic in the Rearview Mirror By Chris Igou, analyst, True Wealth --------------------------------------------------------------- There's only one way to know when a market has moved on from a crisis... It's not necessarily after the crisis is over, either. Instead, it's when a market completely erases the losses it endured from the terrible event. I'm talking about when a market breaks back out to new highs. This simple measure is the market telling us that what used to be a concern isn't anymore. That happened for the U.S. market in August 2020. And the S&P 500 has rallied double digits since then. But many global markets have taken longer to reach new highs. Now, it's happening in German stocks. The German Stock Index ("DAX") broke out to a new 52-week high over the past month. It's this market's way of putting the pandemic in the rearview mirror. And it could mean double-digit gains over the next year. Let me explain... --------------------------------------------------------------- Recommended Links: [TONIGHT: How to Make 2021 the Best Year for Your Money, Ever]( Join us for Stansberry Research's biggest night of the year... as we hand you a complete playbook for how to come out on top of the wildest stock market in 10 years (plus share several stock picks for free). We'll begin at 8 p.m. Eastern time – [click here for details](. --------------------------------------------------------------- [Before Stocks Crash... THIS Will]( Stocks are soaring, and if you're worried about the market top... good news. There's a totally different market you should be paying VERY close attention to. It's a "canary in the coal mine" that could give you a huge clue about when to sell stocks. And knowing what to do in this crash could make you a fortune. (It led some folks to 772% gains in 2009.) [Get the full story here](. --------------------------------------------------------------- Hitting 52-week highs isn't as rare as you might think. When a stock breaks out above a previous high, the old high is no longer the record over that period. This happens fairly often. Markets can hit high after high after high during a bull run. That's why we look for "new" 52-week highs to see if a market is truly breaking out. This highlights the first time a market has hit a high in at least a year. That means it only triggers once over a 52-week period. And it gives us a way to find markets that are just starting to break out. Catching a move like this can lead to significant outperformance for investors. And Germany's DAX Index achieved this feat recently. Take a look... Like the S&P 500 in the U.S., the DAX is Germany's benchmark index. It holds a broad swath of German stocks to represent the entire market. But unlike the S&P 500, the DAX didn't rush back to new highs as quickly after the COVID-19 bust. It took several more months to reach new highs. But now that it has happened, we can expect these gains to continue. Since 1990, breakouts like we are seeing today often lead to outperformance over the next year. It could mean double-digit gains in Germany's market. Check it out... German stocks have been great wealth-generators for three decades... returning a healthy 7.7% a year. But you can do even better by only buying after new highs... Similar cases have led to 7% gains in three months, 10% gains in six months, and a solid 11% gain over the next year. Those are impressive returns for a mature market like Germany. You can easily invest in the German market through the iShares MSCI Germany Fund (EWG). This simple fund tracks the German market and offers the easiest way to make this bet. The COVID-19 crisis isn't over yet. But when it comes to the markets, German stocks have put the pandemic behind them. So if you're looking to add exposure outside of U.S. stocks, history shows buying German stocks is a good idea. Good investing, Chris Igou Editor's note: Make sure you're signed up for our online event tonight. It'll likely be the only time all year you'll see Steve, Austin Root, and Dr. David "Doc" Eifrig sharing their thoughts on the market together... and giving away free recommendations. Plus, it's completely free to tune in. [Just RSVP here to join us at 8 p.m. Eastern time](. Further Reading "We're in the middle of a market Melt Up," Chris says. Stock valuations are sky-high right now. While that might seem like a warning sign that a crash is coming, it's actually good news for a market like today's... Read more here: [What Near-Peak Valuations Mean for Stocks](. Certain sectors serve as a yardstick that points to the health of the overall market. When these "leading sectors" hit new highs, it's usually a sign that the gains can continue... Get the full story here: [Sentiment Hits a Multiyear High in This Crucial Sector](. INSIDE TODAY'S DailyWealth Premium It's time to buy a heavyweight in both renewables and robotics... Germany isn't the only foreign market with good opportunities right now. One Swiss company is dominating both energy and robotics for our future. And it has major upside potential as a result... [Click here to get immediate access](. Market Notes THE BABY BOOMER GENERATION COULD BE A TAILWIND FOR THIS STOCK Today, we're checking in on a company that benefits as the population ages... Longtime readers know our colleague Dr. David Eifrig is bullish on the health care sector. As the Baby Boomer generation gets older and needs more medicines and treatments, health care stocks should see huge gains. Today's company is working hard to provide care for ailing seniors... [Eli Lilly (LLY)]( is a $200 billion pharmaceutical giant. It develops and produces a range of important medications, from diabetes treatments to cancer drugs. The company has also been working on a therapy to slow Alzheimer's disease... In fact, its Alzheimer's drug donanemab recently saw positive results in Phase II clinical trials. With an estimated 5.8 million people suffering from Alzheimer's disease – 80% of those being 75 or older – the need to slow this disease is crucial. As you can see, LLY shares have surged in recent months. The stock is up 75% from its March lows, and it just hit an all-time high. As long as Eli Lilly continues to provide essential treatments to American seniors, this stock should continue higher... --------------------------------------------------------------- [Tell us what you think of this content]( [We value our subscribers’ feedback. To help us improve your experience, we’d like to ask you a couple brief questions.]( [Click here to rate this e-mail]( You have received this e-mail as part of your subscription to DailyWealth. If you no longer want to receive e-mails from DailyWealth [click here](. Published by Stansberry Research. You’re receiving this e-mail at {EMAIL}. Stansberry Research welcomes comments or suggestions at feedback@stansberryresearch.com. This address is for feedback only. For questions about your account or to speak with customer service, call 888-261-2693 (U.S.) or 443-839-0986 (international) Monday-Friday, 9 a.m.-5 p.m. Eastern time. Or e-mail info@stansberrycustomerservice.com. Please note: The law prohibits us from giving personalized investment advice. © 2021 Stansberry Research. All rights reserved. Any reproduction, copying, or redistribution, in whole or in part, is prohibited without written permission from Stansberry Research, 1125 N Charles St, Baltimore, MD 21201 or [www.stansberryresearch.com](. Any brokers mentioned constitute a partial list of available brokers and is for your information only. Stansberry Research does not recommend or endorse any brokers, dealers, or investment advisors. Stansberry Research forbids its writers from having a financial interest in any security they recommend to our subscribers. All employees of Stansberry Research (and affiliated companies) must wait 24 hours after an investment recommendation is published online – or 72 hours after a direct mail publication is sent – before acting on that recommendation. This work is based on SEC filings, current events, interviews, corporate press releases, and what we've learned as financial journalists. It may contain errors, and you shouldn't make any investment decision based solely on what you read here. It's your money and your responsibility.